Home → Focus

The Drug Industry's Triumph Over the DEA Print E-mail
Written by FHI's Week in Review   
Monday, 16 October 2017 17:57

opioid-drugs-medicare Scott Higham and Lenny Bernstein report on Oct. 15, 2017:

Amid a targeted lobbying effort, Congress weakened the DEA's ability to go after drug distributors, even as opioid-related deaths continued to rise, a Washington Post and 60 Minutes investigation finds.

Read more in the current issue of Week in Review>>
Last Updated on Tuesday, 07 November 2017 20:07
'We have entered a new era': Cancer researchers no longer follow a single road to discovery Print E-mail
Written by Andrew Joseph | STAT   
Thursday, 12 October 2017 00:00
Researchers investigating cancer are no longer following a single path toward discovery, said Dr. Jeff Engelman, the vice president and global head of oncology research at Novartis. Instead, over the past five to 10 years, scientists have embarked on an array of approaches, thanks to cutting-edge discoveries that in some cases have come from other scientific fields.

Read More
Last Updated on Friday, 13 October 2017 18:40
Cancer and obesity Print E-mail
Written by FHI's Week in Review   
Monday, 09 October 2017 16:31

A Centers for Disease Control & Prevention (CDC) post dated 10/3/17 examines the relationship between cancer and obesity:

Overweight and obesity are associated with at least 13 different types of cancer. These cancers make up 40% of all cancers diagnosed. About 2 in 3 occur in adults 50-74 years old. Most types of these cancers associated with overweight and obesity increased from 2005-2014. More than half of Americans don't know that overweight and obesity can increase their risk for cancer. Many things are associated with cancer, but avoiding tobacco use and keeping a healthy weight are among the most important things people can do to lower their risk of getting cancer.
Read more in the current issue of Week in Review>>
Last Updated on Tuesday, 31 October 2017 17:16
Face transplantation is the new frontier of plastic surgery Print E-mail
Written by Erez Dayan, MD and Luccie Wo | KevinMD   
Tuesday, 03 October 2017 18:09

Replace like with like - that is the basic principle of reconstructive surgery since its conception in the mid-1500s. Borrow from the healthy part of the body to rebuild the damaged part ... But what do you do when you have run out of places to borrow? What if there simply isn't anything like it anywhere else on the body? How do you reconstruct something as complicated as the human face? The answer - the newest frontier in reconstructive surgery - is transplantation.

The first human face transplant took place in France in 2005, an unfortunate woman whose face was devastated by a severe dog bite. Over thirty face transplants have followed in its steps; each unique from the previous, just as each face is unique from the previous. Each grabbed the media's spotlight and hailed as a medical miracle. Each raises the ethical question "Is it worth it?" Should surgeons perform a "life-enhancing" procedure at the expense of lifelong immunosuppression? Where is the line between reconstructive surgeries to aesthetic surgery in face transplants?
Sobering Stats on Cyber Security in Healthcare Print E-mail
Written by FHI News   
Friday, 29 September 2017 17:16

ecently published an infographic entitled Healthcare's Cyber Security Diagnosis: What Private Equity Needs to Know. It delivers a great snapshot of the crisis - valuable to any health care professional. According to the report:
  • There were 458 total healthcare breaches in 2016.
  • Healthcare consisted of 15% of last year's incidents.
  • Almost a quarter were not detected until months after the incident.
The report also reveals 7 Steps to Strengthen Your Cyber Immune System.

Last Updated on Monday, 16 October 2017 17:56
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 10 of 122

Website design, development, and hosting provided by